Trials / Completed
CompletedNCT00856765
Drug-eluting Balloon in Acute Myocardial Infarction
Randomized Comparison of Drug Eluting Balloon/Bare Metal Stent Versus Drug Eluting Stent Versus Bare Metal Stent for the Treatment of Patients With Acute ST-elevation Myocardial Infarction
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 150 (actual)
- Sponsor
- UMC Utrecht · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The investigators hypothesize that patients with Acute ST Elevation Myocardial Infarction may benefit from primary angioplasty with use of a drug eluting balloon/bare metal stent combination without impairing the process of normal vascular healing and endothelial function. The goals of this study are: 1. To compare 6-month angiographic outcome after primary angioplasty using drug eluting balloon/bare metal stent combination versus drug eluting stent versus bare metal stent. 2. To compare stent apposition and stent endothelialization after primary angioplasty using drug eluting balloon/bare metal stent versus drug eluting stent versus bare metal stent. 3. To compare coronary endothelial function after primary angioplasty using drug eluting balloon/bare metal stent versus drug eluting stent versus bare metal stent.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Drug eluting balloon | Percutaneous transluminal coronary balloon angioplasty catheter eluting paclitaxel |
| DEVICE | Bare metal stent | Bare metal stent |
| DEVICE | Drug eluting stent | Paclitaxel eluting stent |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2011-06-01
- Completion
- 2016-11-01
- First posted
- 2009-03-06
- Last updated
- 2017-05-02
Locations
2 sites across 2 countries: Italy, Netherlands
Source: ClinicalTrials.gov record NCT00856765. Inclusion in this directory is not an endorsement.